Literature DB >> 72426

Polio antibodies and HLA antigens in amyotrophic lateral sclerosis.

M Jokelainen, A Tiilikainen, K Lapinleimu.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal, progressive disease of the central nervous system. Its possible association with poliomyelitis was studied by measuring neutralizing antibodies against polio virus types 1, 2 and 3 in the sera and cerebrospinal fluids of 11 ALS-patients, but antibody titers did not markedly differ from those of the controls. The HLA antigens of 12 ALS patients were also determined, in order to reveal any possible genetically-determined susceptibility to the disease. Possible association of ALS with HLA-Bw40 was noted. In addition, the Bw40 antigen seemed to be associated with milder progression of the disease. The lymphocytes of the ALS patients seemed defective in their capacity to stimulate allogenic lymphocytes, possibly due to a relative decrease of B cells in the peripheral blood. Joint efforts of study groups of neuroepidemiology, immunology and genetics should be mobilized to reveal the true nature of these findings.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 72426     DOI: 10.1111/j.1399-0039.1977.tb00755.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  4 in total

Review 1.  Immunology of amyotrophic lateral sclerosis.

Authors:  N R Cashman; M E Gurney; J P Antel
Journal:  Springer Semin Immunopathol       Date:  1985

2.  A study of histocompatibility antigens in patients with motor neuron disease in the northern region of England.

Authors:  E Woo; S Nightingale; D J Dick; T J Walls; J M French; D Bates
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-04       Impact factor: 10.154

Review 3.  The immunogenetics of neurological disease.

Authors:  Maneesh K Misra; Vincent Damotte; Jill A Hollenbach
Journal:  Immunology       Date:  2017-12-11       Impact factor: 7.397

Review 4.  On the possible role of viruses in the aetiology of motor neurone disease: a review.

Authors:  P G Kennedy
Journal:  J R Soc Med       Date:  1990-12       Impact factor: 18.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.